0000320335-20-000024.txt : 20200422 0000320335-20-000024.hdr.sgml : 20200422 20200422164622 ACCESSION NUMBER: 0000320335-20-000024 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20200422 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200422 DATE AS OF CHANGE: 20200422 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBE LIFE INC. CENTRAL INDEX KEY: 0000320335 STANDARD INDUSTRIAL CLASSIFICATION: LIFE INSURANCE [6311] IRS NUMBER: 630780404 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08052 FILM NUMBER: 20808351 BUSINESS ADDRESS: STREET 1: 3700 SOUTH STONEBRIDGE DRIVE CITY: MCKINNEY STATE: TX ZIP: 75070 BUSINESS PHONE: 972-569-4000 MAIL ADDRESS: STREET 1: 3700 SOUTH STONEBRIDGE DRIVE CITY: MCKINNEY STATE: TX ZIP: 75070 FORMER COMPANY: FORMER CONFORMED NAME: TORCHMARK CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: TORCHMARK CORP SAVINGS & INVESTMENT PLAN DATE OF NAME CHANGE: 19820825 FORMER COMPANY: FORMER CONFORMED NAME: LIBERTY NATIONAL INSURANCE HOLDING CO DATE OF NAME CHANGE: 19820701 8-K 1 gl-20200422.htm 8-K EARNINGS RELEASE Q1 2020 gl-20200422
0000320335false00003203352020-04-222020-04-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 22, 2020
GLOBE LIFE INC.
(Exact name of registrant as specified in its charter)
Delaware 001-0805263-0780404
(State or other jurisdiction
of incorporation)
 
(Commission
File No.)
(I.R.S. Employer
ID No.)
3700 South Stonebridge Drive, McKinney, Texas 75070
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (972) 569-4000
N/A
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a.-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchanged on which registered
Common Stock, $1.00 par value per shareGLNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐



Item 2.02 Results of Operations and Financial Condition.
On April 22, 2020, Globe Life Inc. issued a press release announcing its first quarter 2020 financial results. A copy of the press release is incorporated herein by reference and is provided as Exhibit 99.1.
In accordance with General Instruction B.2 of Form 8-K, the information included or incorporated in this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be set forth by specific reference in such filing.
Item 9.01 Financial Statement and Exhibits.
(a)Financial Statements of businesses acquired.
Not applicable.
(b)Pro forma financial information.
Not applicable.
(c)Shell company transactions.
Not applicable
(d)Exhibits.
(104) Cover Page Interactive Data File (embedded within the Inline XBRL document)





SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 GLOBE LIFE INC.
Date: April 22, 2020 
 /s/ Christopher T. Moore
 Christopher T. Moore
Corporate Senior Vice President,
Associate Counsel and Corporate Secretary

 EX-99.1 2 q1fy2020earningsrelease.htm Q1 2020 EARNINGS RELEASE Document

globelifeheader1.gif

GLOBE LIFE INC. REPORTS
First Quarter 2020 Results

McKinney, TX, April 22, 2020—Globe Life Inc. (NYSE: GL) reported today that for the quarter ended March 31, 2020, net income was $1.52 per diluted common share, compared with $1.65 per diluted common share for the year-ago quarter. Net operating income for the quarter was $1.73 per diluted common share, compared with $1.64 per diluted common share for the year-ago quarter.

COVID-19—The Company is closely monitoring the impact of the novel coronavirus (COVID-19) on the Company's business, distribution channels, employees, and policyholders. The Company did not incur material claims or significant disruptions to the business for the three months ended March 31, 2020. However, we do foresee some adverse impact to near-term sales activity, premium, policy benefits, and regulatory capital, although the full extent to which COVID-19 impacts financial results remains uncertain as of the date of this earnings release.

As a Company, we are committed to our employees, agents, customers, vendors, and shareholders in our resolve to maintain a stable and secure business. The Company has continued to operate at nearly full capacity while taking the necessary steps to ensure the health and safety of our employees through adherence to CDC and local government work guidelines. In addition, the Company has converted to virtual sales and recruiting processes to enable our agents to continue their activities. The Company continues to diligently monitor and respond to the coronavirus outbreak and is taking every reasonable measure to make sure customers continue to be served without interruption.


HIGHLIGHTS:
lNet income as an ROE was 9.6%. Net operating income as an ROE excluding net unrealized gains on fixed maturities was 14.1%.
lLife underwriting margin at the American Income Life Division increased over the year-ago quarter by 7%. Health underwriting margin at the Family Heritage Division increased over the year-ago quarter by 11%.
lLife premiums increased over the year-ago quarter by 7% at the American Income Life Division. Health premiums increased over the year-ago quarter by 8% at the Family Heritage Division.
lLife net sales at the American Income Life Division increased over the year-ago quarter by 9%.
lTotal health net sales increased over the year-ago quarter by 9%.
l1.6 million shares of Globe Life Inc. common stock were repurchased during the quarter.







Note: As used in the earnings release, "Globe Life," the "Company," "we," "our," and "us" refer to Globe Life Inc., a Delaware corporation incorporated in 1979, its subsidiaries and affiliates.
1
GL Q1 2020 Earnings Release
GLOBE LIFE INC.
Earnings Release—Q1 2020
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

RESULTS OF OPERATIONS
Net operating income, a non-GAAP(1) financial measure, has been used consistently by Globe Life’s management for many years to evaluate the operating performance of the Company, and is a measure commonly used in the life insurance industry. It differs from net income primarily because it excludes certain non-operating items such as realized investment gains and losses and certain significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.
The following table represents Globe Life's operating summary for the three months ended March 31, 2020 and 2019:
Operating Summary
Per Share
Three Months Ended
March 31,		Three Months Ended
March 31,
20202019%
Chg.		20202019%
Chg.
Insurance underwriting income(2)
$1.66  $1.56  6$181,243  $174,819  4
Excess investment income(2)
0.57  0.58  (2)62,737  65,555  (4)
Parent company expense(0.02) (0.02) (2,331) (2,643) 
Income tax(0.43) (0.41) 5(46,760) (46,590) —
Stock compensation benefit (expense), net of tax(0.06) (0.06) (6,145) (6,397) 
Net operating income 1.73  1.64  5188,744  184,744  2
Reconciling items, net of tax:
Realized gain (loss)—investments0.04  0.01  4,548  1,050  
Provision for credit losses(0.23) —  (25,165) —  
Part D adjustments—discontinued operations—  —  —  (49) 
Administrative settlements—  —  —  (400) 
Legal proceedings(0.02) —  (2,587) —  
Net income(3)
$1.52  $1.65  $165,540  $185,345  
Weighted average diluted shares outstanding 109,132  112,329  
(1)GAAP is defined as accounting principles generally accepted in the United States of America.
(2)Definitions included within this document.
(3)A GAAP-basis consolidated statement of operations is included in the appendix of this report.


Note: Tables in this earnings release may not sum due to rounding.



2
GL Q1 2020 Earnings Release
GLOBE LIFE INC.
Earnings Release—Q1 2020
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

MANAGEMENT VS. GAAP MEASURES

Shareholders' equity, excluding net unrealized gains on fixed maturities, and book value per share, excluding net unrealized gains on fixed maturities, are non-GAAP measures that are utilized by management to view the business without the effect of unrealized gains or losses which are primarily attributable to fluctuation in interest rates associated with the available-for-sale portfolio. Management views the business in this manner because the Company has the ability and generally, the intent, to hold investments to maturity and meaningful trends can more easily be identified without the fluctuations. Shareholders' equity and book value per share are the most directly comparable GAAP measures.
Three Months Ended
March 31,
20202019
Net income as an ROE(1)
9.6 %12.9 %
Net operating income as an ROE (excluding net unrealized gains on fixed maturities)
14.1 %14.7 %
March 31,
20202019
Shareholders' equity$6,520,282  $6,043,426  
Impact of adjustment to exclude net unrealized gains on fixed maturities(1,210,561) (969,242) 
Shareholders' equity, excluding net unrealized gains on fixed maturities$5,309,721  $5,074,184  
Book value per share$60.98  $54.13  
Impact of adjustment to exclude net unrealized gains on fixed maturities(11.32) (8.68) 
Book value per share, excluding net unrealized gains on fixed maturities$49.66  $45.45  
(1) Calculated using average shareholders' equity for the measurement period.

INSURANCE OPERATIONS—comparing Q1 2020 with Q1 2019:

Life insurance accounted for 73% of the Company’s insurance underwriting margin for the quarter and 70% of total premium revenue.

Health insurance accounted for 26% of the Company's insurance underwriting margin for the quarter and 30% of total premium revenue.

Net sales of life insurance increased 5%, while net health sales increased 9%.


The following table summarizes Globe Life's premium revenue by product type for the three months ended March 31, 2020 and 2019:

Insurance Premium Revenue
Quarter Ended
March 31, 2020March 31, 2019%
Chg.
Life insurance$649,630  $624,289  4
Health insurance280,205  266,684  5
Total$929,835  $890,973  4

3
GL Q1 2020 Earnings Release
GLOBE LIFE INC.
Earnings Release—Q1 2020
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

INSURANCE UNDERWRITING INCOME
Insurance underwriting margin is management’s measure of profitability of the Company's life, health, and annuity segments’ underwriting performance, and consists of premiums less policy obligations, commissions and other acquisition expenses. Insurance underwriting income is the sum of the insurance underwriting margins of the life, health, and annuity segments, plus other income, less insurance administrative expenses. It excludes the investment segment, Parent Company expense, stock compensation expense and income taxes. Management believes this information helps provide a better understanding of the business and a more meaningful analysis of underwriting results by distribution channel. Insurance underwriting income, a non-GAAP measure, is a component of net operating income, which is reconciled to net income in the Results of Operations section above.
The following table summarizes Globe Life's insurance underwriting income by segment for the three months ended March 31, 2020 and 2019:
Insurance Underwriting Income
Quarter Ended
March 31, 2020% of
Premium		March 31, 2019% of
Premium		%
Chg.
Insurance underwriting margins:
Life$178,803  28$169,839  275
Health63,465  2361,514  233
Annuity2,270  2,416  
244,538  233,769  5
Other income325  241  
Administrative expenses(63,620) (59,191) 7
Insurance underwriting income$181,243  $174,819  4
Per share$1.66  $1.56  6

Administrative expenses were $64 million, up 7.5% from the year-ago quarter. The ratio of administrative expenses to premium was 6.8%, compared with 6.6% for the year-ago quarter.

4
GL Q1 2020 Earnings Release
GLOBE LIFE INC.
Earnings Release—Q1 2020
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

LIFE INSURANCE RESULTS BY DISTRIBUTION CHANNEL

Our distribution channels consist of the following exclusive agencies, American Income Life Division (American Income), Liberty National Division (Liberty National) and Family Heritage Division (Family Heritage); an independent agency, United American Division (United American); and our Direct to Consumer Division.

Total premium, underwriting margins, first-year collected premium and net sales by all distribution channels are shown at https://investors.globelifeinsurance.com at "Financial Reports and Other Financial Information."
Life Underwriting Margin
Quarter Ended
March 31,
20202019
Amount% of PremiumAmount% of Premium% Chg.
American Income $99,815  33  $93,309  33  7
Direct to Consumer 38,475  17  37,368  17  3
Liberty National 18,939  26  17,981  25  5
Other 21,574  40  21,181  39  2
Total$178,803  28  $169,839  27  5

Life Premium
Quarter Ended
March 31,
20202019%
Chg.
American Income $302,852  $281,767  7
Direct to Consumer 220,043  217,559  1
Liberty National 72,868  70,717  3
Other 53,867  54,246  (1)
Total$649,630  $624,289  4

Life Net Sales(1)
Quarter Ended
March 31,
20202019%
Chg.
American Income $62,869  $57,551  9
Direct to Consumer 32,547  32,447  —
Liberty National 12,488  12,259  2
Other 2,709  3,083  (12)
Total$110,613  $105,340  5
(1)Net sales is annualized premium issued (gross premium that would be received during the policies' first year in force and assuming that none of the policies lapsed or terminated), net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period has expired. We believe that net sales is a better indicator of the rate of premium growth than annualized premium issued.

5
GL Q1 2020 Earnings Release
GLOBE LIFE INC.
Earnings Release—Q1 2020
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

HEALTH INSURANCE RESULTS BY DISTRIBUTION CHANNEL

Health Underwriting Margin
Quarter Ended
March 31,
20202019
Amount% of PremiumAmount% of Premium% Chg.
United American $15,523  14  $15,887  15  (2)
Family Heritage 19,585  25  17,716  25  11
Liberty National 11,899  25  11,967  25  (1)
American Income 13,527  53  12,750  53  6
Direct to Consumer2,931  15  3,194  16  (8)
Total$63,465  23  $61,514  23  3

Health Premium
Quarter Ended
March 31,
20202019%
Chg.
United American $110,059  $102,905  7
Family Heritage 76,983  71,264  8
Liberty National 47,640  48,156  (1)
American Income 25,727  24,099  7
Direct to Consumer 19,796  20,260  (2)
Total$280,205  $266,684  5

Health Net Sales(1)
Quarter Ended
March 31,
20202019%
Chg.
United American $14,464  $14,894  (3)
Family Heritage 16,281  13,030  25
Liberty National 5,943  5,565  7
American Income 4,752  3,899  22
Direct to Consumer 590  1,145  (48)
Total$42,030  $38,533  9
(1)Net sales is annualized premium issued (gross premium that would be received during the policies' first year in force and assuming that none of the policies lapsed or terminated), net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period has expired. We believe that net sales is a better indicator of the rate of premium growth than annualized premium issued.
6
GL Q1 2020 Earnings Release
GLOBE LIFE INC.
Earnings Release—Q1 2020
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

PRODUCING EXCLUSIVE AGENT COUNT RESULTS BY DISTRIBUTION CHANNEL
Quarterly Average
Producing Agent Count(1)
End of Quarter
Agent Count
Quarter EndedQuarter Ended
March 31,December 31,March 31,December 31,
20202019% Chg.201920202019% Chg.2019
American Income7,630  6,865  11  7,631  8,044  7,233  11  7,551  
Liberty National 2,648  2,179  22  2,534  2,688  2,297  17  2,660  
Family Heritage 1,227  1,002  22  1,228  1,290  1,020  26  1,286  

(1) The quarterly average producing agent count is based on the actual count at the end of each week during the period.


INVESTMENTS

Management uses excess investment income as the measure to evaluate the performance of the investment segment. It is defined as net investment income less both the required interest attributable to net policy liabilities and the interest on debt. We also view excess investment income per diluted common share as an important and useful measure to evaluate performance of the investment segment, since it takes into consideration our stock repurchase program.

The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.
Excess Investment Income
Quarter Ended
March 31,
20202019%
Chg.
Net investment income$228,991  $226,673  1
Required interest:
Interest on net policy liabilities(1)
(145,446) (139,840) 4
Interest on debt(20,808) (21,278) (2)
Total required interest(166,254) (161,118) 3
Excess investment income$62,737  $65,555  (4)
Per share$0.57  $0.58  (2)
(1)Interest on net policy liabilities is a component of total policyholder benefits, a GAAP measure.

Net investment income increased 1%, while average invested assets increased 4%. Required interest on net policy liabilities increased 4%, in line with the increase in average net policy liabilities. The weighted average discount rate for the net policy liabilities was 5.7% and was in line with the year-ago quarter.

7
GL Q1 2020 Earnings Release
GLOBE LIFE INC.
Earnings Release—Q1 2020
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

The composition of the investment portfolio at book value at March 31, 2020 is as follows:
Investment Portfolio
As of
March 31, 2020
Amount% of Total
Fixed maturities at fair value(1)
$17,879,541  94 %
Policy loans579,133  3  
Other long-term investments(2)
377,239  2  
Short-term investments272,601  1  
Total$19,108,514  100 %
(1) On January 1, 2020, the Company prospectively adopted ASU 2016-13 Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. For available-for-sale fixed maturities, the standard removed the loss impairment methodology of a direct write-down of the amortized cost and replaced it with allowances for credit losses. As of March 31, 2020, fixed maturities at amortized cost were $16.4 billion less $32 million for allowance for credit losses.
(2) Includes $212 million of investments accounted for under the fair value option which have a cost of $202 million as of March 31, 2020.

Fixed maturities at amortized cost, net of allowance for credit losses by asset class as of March 31, 2020 are as follows:
Fixed Maturity Portfolio by Sector
As of
March 31, 2020
Investment GradeBelow Investment GradeTotal Amortized Cost
Corporate bonds(1)
$13,503,018  $669,301  $14,172,319  
Municipals1,582,294  —  1,582,294  
Government-sponsored enterprises318,887  —  318,887  
Government & agencies77,903  —  77,903  
Collateralized debt obligations—  56,733  56,733  
Other asset-backed securities117,779  14,175  131,954  
Total$15,599,881  $740,209  $16,340,090  
(1) Please see our website for information regarding our energy portfolio.

Below are fixed maturities available for sale by amortized cost, allowance for credit losses, and fair value at March 31, 2020 and the corresponding amounts of net unrealized gains recognized in accumulated other comprehensive income (loss).

Amortized
Cost		Allowance for Credit LossesNet Unrealized GainsFair
Value
March 31, 2020$16,371,944  $(31,854) $1,539,451  $17,879,541


At amortized cost, net of allowance for credit losses, 95% of fixed maturities (97% at fair value) were rated “investment grade.” The fixed maturity portfolio earned an annual taxable equivalent effective yield of 5.39% during the first quarter of 2020, compared with 5.53% in the year-ago quarter.

Globe Life is not a party to any credit default swaps and does not participate in securities lending.


8
GL Q1 2020 Earnings Release
GLOBE LIFE INC.
Earnings Release—Q1 2020
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

Comparable information for acquisitions of fixed maturity investments is as follows:
Fixed Maturity Acquisitions
Quarter Ended
March 31,
20202019
Amount$211,754  $450,664  
Average annual effective yield3.8 %4.9 %
Average ratingA+  A+  
Average life (in years) to:
Next call14.9  19.5  
Maturity27.0  28.2  

SHARE REPURCHASE:

During the quarter, the Company repurchased 1.6 million shares of Globe Life Inc. common stock at a total cost of $139 million for an average share price of $85.47. The Company has temporarily postponed future repurchases while we evaluate the impact that the COVID-19 pandemic will have on our operations.

LIQUIDITY/CAPITAL:

Globe Life's operations consist primarily of writing basic protection life and supplemental health insurance policies which generate strong and stable cash flows. These cash flows are not impacted by the volatile equity markets. While capital at the insurance companies is sufficient to support operations, the Company determined that it would be prudent to obtain additional financing in case additional liquidity was needed. As such, on April 9, 2020, the Company entered into a new 364 day $300 million term loan facility and drew the entire $300 million on April 15, 2020. Including $247 million of liquid assets that were available to the Company as of March 31, 2020, the Company has access to approximately $547 million of liquid assets for future liquidity needs. See the Form 8-K for the announcement about the term loan facility on www.sec.gov.

EARNINGS GUIDANCE FOR THE YEAR ENDING DECEMBER 31, 2020:

Globe Life projects that net operating income per share will be in the range of $6.65 to $7.15 for the year ending December 31, 2020. The reduction in our earnings guidance, as well as the wider range, reflects the impact of COVID-19 on our operations.

NON-GAAP MEASURES:

In this news release, Globe Life includes non-GAAP measures to enhance investors' understanding of management's view of the business. The non-GAAP measures are not a substitute for GAAP, but rather a supplement to increase transparency by providing broader perspective. Globe Life's definitions of non-GAAP measures may differ from other companies' definitions. More detailed financial information, including various GAAP and non-GAAP measurements, is located at https://investors.globelifeinsurance.com on the Investors page under “Financial Reports and Other Financial Information."


9
GL Q1 2020 Earnings Release
GLOBE LIFE INC.
Earnings Release—Q1 2020
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

CAUTION REGARDING FORWARD-LOOKING STATEMENTS:

This press release may contain forward-looking statements within the meaning of the federal securities laws, including statements related to the expected impact of the COVID-19 outbreak on our business operations, financial results and financial condition. These prospective statements reflect management’s current expectations, but are not guarantees of future performance. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to: 1)Economic and other conditions, including the COVID-19 pandemic and its impact on the U.S. economy, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions; 2)Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement); 3)Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance; 4)Interest rate changes that affect product sales and/or investment portfolio yield; 5)General economic, industry sector or individual debt issuers’ financial conditions (including developments and volatility arising from the COVID-19 pandemic, particularly in certain industries that may comprise part of our investment portfolio)that may affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities; 6)Changes in pricing competition; 7)Litigation results; 8)Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from operating during the COVID-19 pandemic); 9)The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators; 10)The customer response to new products and marketing initiatives; 11)Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized; 12)Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems; 13) the severity, magnitude and impact of the COVID-19 pandemic, including effects of the pandemic and the effects of the U.S. government’s and other businesses’ response to the pandemic, on our operations and personnel, and on commercial activity and demand for our products; and 14) Globe Life’s ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period as a result of the COVID-19 pandemic. Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission. Globe Life specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.

EARNINGS RELEASE CONFERENCE CALL WEBCAST:

Globe Life will provide a live audio webcast of its first quarter 2020 earnings release conference call with financial analysts at 11:00 am (Eastern) tomorrow, April 23, 2020. Access to the live webcast and replay will be available at https://investors.globelifeinsurance.com on the Calls and Meetings page, at the Conference Calls on the Web icon. Immediately following this press release, supplemental financial reports will be available before the conference call on the Investors page menu of the Globe Life website at “Financial Reports.”

For additional information contact:Mike Majors, Executive Vice President - Administration and Investor Relations
Globe Life Inc.
3700 South Stonebridge Drive
P. O. Box 8080
McKinney, Texas 75070-8080
Phone: 972-569-3627 or email: investors@globe.life
Website: https://investors.globelifeinsurance.com

10
GL Q1 2020 Earnings Release
GLOBE LIFE INC.
Earnings Release—Q1 2020
(Dollar amounts in thousands, except share and per share data)
(Unaudited)

APPENDIX

GLOBE LIFE INC.
GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three Months Ended
March 31,
 20202019
Revenue:
Life premium$649,630  $624,289  
Health premium280,205  266,684  
Other premium—  —  
Total premium929,835  890,973  
Net investment income228,991  226,673  
Realized gains (losses)5,757  1,329  
Provision for credit losses(31,854) —  
Other income325  241  
Total revenue1,133,054  1,119,216  
Benefits and expenses:
Life policyholder benefits421,670  409,692  
Health policyholder benefits178,711  170,017  
Other policyholder benefits7,588  8,048  
Total policyholder benefits607,969  587,757  
Amortization of deferred acquisition costs143,837  135,822  
Commissions, premium taxes, and non-deferred acquisition costs78,937  73,465  
Other operating expense78,582  72,793  
Interest expense20,808  21,278  
Total benefits and expenses930,133  891,115  
Income before income taxes202,921  228,101  
Income tax benefit (expense)(37,381) (42,707) 
Income from continuing operations165,540  185,394  
Discontinued operations:
Income (loss) from discontinued operations, net of tax—  (49) 
Net income$165,540  $185,345  
Total basic net income per common share$1.54  $1.68  
Total diluted net income per common share$1.52  $1.65  

11
GL Q1 2020 Earnings Release
 EX-101.SCH 3 gl-20200422.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover page link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 gl-20200422_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 gl-20200422_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 gl-20200422_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name City Area Code City Area Code Cover page. Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 7 gl-20200422_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 globelifeheader1.gif begin 644 globelifeheader1.gif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end EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "gl-20200422.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "gl-20200422_cal.xml" ] }, "definitionLink": { "local": [ "gl-20200422_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "gl-20200422.htm" ] }, "labelLink": { "local": [ "gl-20200422_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "gl-20200422_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "gl-20200422.xsd" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "gl", "nsuri": "http://www.globelifeinsurance.com/20200422", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "gl-20200422.htm", "contextRef": "i8fc60d9ba6664f2995ba6687d1294e45_D20200422-20200422", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover page", "role": "http://www.globelifeinsurance.com/role/Coverpage", "shortName": "Cover page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "gl-20200422.htm", "contextRef": "i8fc60d9ba6664f2995ba6687d1294e45_D20200422-20200422", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.globelifeinsurance.com/role/Coverpage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 13 0000320335-20-000024-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000320335-20-000024-xbrl.zip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htm IDEA: XBRL DOCUMENT v3.20.1
Cover page
Apr. 22, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date Apr. 22, 2020
Entity Registrant Name GLOBE LIFE INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-08052
Entity Tax Identification Number 63-0780404
Entity Address, Address Line One 3700 South Stonebridge Drive
Entity Address, City or Town McKinney
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75070
City Area Code 972
Local Phone Number 569-4000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $1.00 par value per share
Trading Symbol GL
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0000320335
Amendment Flag false
XML 15 gl-20200422_htm.xml IDEA: XBRL DOCUMENT 0000320335 2020-04-22 2020-04-22 0000320335 false 8-K 2020-04-22 GLOBE LIFE INC. DE 001-08052 63-0780404 3700 South Stonebridge Drive McKinney TX 75070 972 569-4000 false false false false Common Stock, $1.00 par value per share GL NYSE false XML 16 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover page Sheet http://www.globelifeinsurance.com/role/Coverpage Cover page Cover 1 false false All Reports Book All Reports gl-20200422.htm gl-20200422.xsd gl-20200422_cal.xml gl-20200422_def.xml gl-20200422_lab.xml gl-20200422_pre.xml q1fy2020earningsrelease.htm http://xbrl.sec.gov/dei/2019-01-31 true true XML 17 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}